Clinical Trial Update: Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder [Phase 4]

View source ↗

Summary

Phase 4 open-label extension trial evaluating the efficacy and safety of fesoterodine in elderly patients with overactive bladder. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Fesoterodine (fesoterodine)

Snippet

Sponsor: Pfizer | Conditions: Urinary Bladder, Overactive | Phase 4 | Status: COMPLETED | Results posted: 2013-05-15